hledat

Vaše výsledky

Zobrazuje se 10 z 10 výsledky

On 26 Avril 2023, the European Commission put forward a 'pharmaceutical package' to revise the EU's pharmaceutical legislation and make medicines more available, accessible and affordable, while supporting the competitiveness and attractiveness of the EU pharmaceutical industry, with higher environmental standards. The package includes proposals for a new directive and a new regulation, which would replace the existing pharmaceutical legislation, including the legislation on medicines for children ...

Genderové rozměry energetické chudoby

Ve stručnosti 15-02-2023

Mezinárodní den žen se letos slaví na pozadí ruské války na Ukrajině. Tento konflikt ohrožováním nedostatky energie prohloubil inflační dopady postpandemického oživení, což vedlo ke krizi životních nákladů v Evropě. Výbor Evropského parlamentu pro práva žen a rovnost pohlaví (FEMM) si tento den připomíná setkáními s vnitrostátními parlamenty dne 1. března 2023. Na pořadu jednání: dopad rostoucích cen energií na ženy a případná opatření k jeho zmírnění.

Plenary round-up – January I 2023

Ve stručnosti 20-01-2023

The highlights of the January I 2023 plenary session were debates on the conclusions of the European Council meeting of 15 December 2022 and the presentation of activities planned under the Swedish Presidency of the Council of the European Union. The session opened with a ceremony marking the 30th anniversary of the single market, followed by a debate with the Council and Commission on the matter. Debates were held on the surge of respiratory infections and the shortage of medication in Europe; on ...

On 11 November 2020, the European Commission adopted a proposal to strengthen the European Medicines Agency (EMA). The proposed regulation would allow the EMA, among other things, to better anticipate possible shortages of medicinal products and ensure their timely development, with the aim of improving the EU's capacity to respond to health emergencies. The European Parliament's Committee on the Environment, Public Health and Food Safety adopted its report on 22 June 2021. This is due to be voted ...

Access to medicinal products

Studie 01-05-2021

There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs. Because of national differences in health systems and market characteristics, access to medicine is not evenly distributed across the European Union. In response to observed problems with access to medicine, in 2017 the European Parliament adopted a resolution containing 58 recommendations ...

The novel coronavirus outbreak is an unprecedented public health crisis with far-reaching consequences. It has highlighted the EU’s long-existing structural problems related to the supply of medicines, and the dependency on third-country import for certain essential and critical medicines and ingredients. While public health policy, including the organisation of the delivery of healthcare and the sales of medicines remains in the competence of the Member States, it has also become clear that cooperation ...

Addressing shortages of medicines

Briefing 28-04-2020

Medicines shortages have been a growing problem in the European Union (EU) in recent years. As the coronavirus outbreak unfolds, the risk of bottlenecks in the supply of medicines to patients has become particularly high. More broadly, problems with the availability of, and access to, new medicines – most frequently associated with high-priced medicines – have also been a central topic in political debates for some time now. The causes underlying medicines shortages are complex and multi-dimensional ...

Trafficking in Human Organs

Studie 18-06-2015

The commercial trade in human organs, including trafficking in persons for organ removal has developed into a global problem. This report describes the current situation regarding international organ trafficking, committed often by transnational criminal networks. It zooms in on the role of traffickers, international brokers, health professionals, and the recipients and suppliers. To combat and prevent organ commercialism and trafficking, a legal framework for the criminalisation of trafficking offences ...

The crisis in Ukraine has led to seven rounds of sanctions between Russia and the EU – and may well lead to more. Energy is the most alarming casualty in this clash, with the EU and Russia largely interdependent in the domain. The level of dependency among EU Member States varies greatly, as does their ability to respond to Russian warnings and actions. Ukraine's gas situation is also at stake. The Russian gas exporter Gazprom ceased exporting to Ukraine in June. In late September, gas cuts were ...

Reserves of rare earth elements are, as is their mining, unevenly distributed across the world. China has about 50% of known world reserves and until very recently was behind 95% of global supplies. It has reduced its export quotas drastically since 2010, arguing that the country had paid a heavy price for its mining activity in the form of resource depletion and severe environmental damage. In March 2012, together with Japan and the US, the EU demanded dispute settlement consultations in the World ...